Myasthenia gravis (MG) or its treatments may lead to urinary symptoms. Studies suggest a link between overactive bladder symptoms and a common MG medication called pyridostigmine. Urinary symptoms in ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Nicholas J.
Early and accurate diagnosis holds immense importance as it allows for timely treatment to manage symptoms and enhance patients' quality of life, even in the absence of a cure. Tecan, with 40 years of ...
Acupuncture may help reduce symptoms and improve overall quality of life when used as a complementary therapy for myasthenia gravis (MG), but further research is needed to explore its effectiveness.
At 75, I’ve learned life is full of experiences and opportunities. This illness is just another one. I wouldn’t have chosen to get a diagnosis of myasthenia gravis (MG) just before turning 70. But ...
MG Lexicon will help patients and medical professionals communicate and share common information concerning the rare autoimmune, neuromuscular disease myasthenia gravis BOSTON, Dec. 5, 2025 ...
The first study to use an RNA-based chimeric antigen receptor T-cell (rCAR-T) therapy in autoimmune disease showed people with generalized myasthenia gravis tolerated the treatment well and ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Nicholas Silvestri ...
Myasthenia gravis (MG) in children and adolescents to age 18 -- juvenile MG -- includes clinically significant developmental issues like puberty that are not present in adult disease. Despite this, ...
DUBLIN--(BUSINESS WIRE)--The "Myasthenia Gravis: Epidemiology Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. Myasthenia Gravis: Epidemiology Forecast to 2028 ...
Using US claims data, the authors evaluated oral glucocorticoid (GC) use at 5 time points during their retrospective analysis: 3 months before starting efgartigimod and 3, 6, 9, and 12 months after ...